L’Institut Servier Research Grants are awarded for one year of research, enabling:
- French researchers, future PhDs or postdocs in medicine or pharmacy wishing to acquire additional training and/or supplement their research project abroad.
- Or foreign researchers, future PhDs or postdocs wishing to supplement their training in France, with priority given to the following therapeutic areas: oncology, immuno-inflammatory diseases, neurodegenerative diseases, and paediatric diseases.
- Reason for the mobility and why it is necessary
- Candidate’s scientific studies and publications
- Project utility, relevance and scientific quality
- Candidate’s personal implication in the project
- Added value for the research team
- Candidate’s plans for further study after project completion
Grant Winners of the October 2022 session
- Research Project: «Meta-lune: Meta-learning in the management of Lupus Nephritis».
- Host laboratory: Pr Olivier GEVAERT, Stanford Center for Biomedical Informatics Research, Stanford, USA.
- Research Project: «Endpoints in marginal zone lymphomas: evaluation of a surrogate marker for PFS and assessment of emerging prognostic markers».
- Host laboratory: Pr Jim CERHAN, Mayo Clinic, Rochester, USA.
- Research Project: «CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry (CHOICE-MI)».
- Host laboratory: Pr J. GRANADA, Cardiovascular Research Foundation, New York, USA.
- Research Project: «Impact of adipocyte “browning” on the immune component of breast cancer: a new obesity-cancer link».
- Host laboratory: Dr Daniela QUAIL, Université McGill, Institut du Cancer Rosalind et Morris Goodman, Montréal, Canada.
- Research Project: «Analyze the role of p38a MAP kinase in the homeostatic neuronal regeneration in children with chemotherapy-induced neuropathy».
- Host laboratory: Pr Miriam GOODMAN, Stanford University, Stanford, USA.
- Research Project: «Enhancing chimeric antigen receptor (CAR) T-cell therapy-mediated anti-tumoral immunity: role of Natural Killer cells».
- Host laboratory: Pr Rizwan ROMEE, Dana Farber Cancer Institute, Boston, USA.
- Research Project: «Spatial characterization of the dynamic changes in early triple negative breast cancer patients treated by neodjuvant chemotherapy plus PD1 blockade».
- Host laboratory: Pr Kai Wucherpfennig, Dana-Farber Cancer Institute, Boston, USA.
- Research Project: «Characterization of PTPN22 function and its regulation in human B cells»
- Host laboratory: Pr Eric MEFFRE, Stanford Medical School, Stanford, USA.
- Research Project: «Augmented Interventional Oncology».
- Host laboratory: Pr Bradford WOOD, NIH Center for Interventional Oncology, Bethesda, USA.